Diabetes mellitus

Endocrinology

Glucocorticoid Receptor Inactivation in Hepatocytes Reveals Crucial Role in Glucose Metabolism

Scientists in Germany have made a groundbreaking discovery that inactivating the glucocorticoid receptor (GR) in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in diabetes. This finding has significant implications for the treatment of diabetes mellitus, as it suggests that liver-specific glucocorticoid antagonists could be beneficial in controlling diabetic hyperglycemia.

Endocrinology

Recombinant Hepatocyte Growth Factor Accelerates Cutaneous Wound Healing in Diabetic Mouse Model

Researchers in Japan have discovered that recombinant hepatocyte growth factor (HGF) significantly accelerates cutaneous wound healing in a diabetic mouse model. The study found that topical administration of HGF, along with basic fibroblast growth factor (bFGF), promoted wound closure and re-epithelialization. Notably, HGF treatment enhanced expansion of granulation tissue, stimulated